SIGMA Healthcare has today launched pathology health screenings throughout its Amcal Pharmacy network across Australia.
Named Sigma Pathology Health Screening, the company explained the new service would be provided in accordance with best practice by SmartHealth utilising their network of 1,500 accredited participating collection centres and laboratories throughout Australia.
Amcal senior pharmacist James Nevile said the health screening service would benefit members of the community who were currently disengaged with the traditional healthcare system.
"We recognise the important role that pharmacists play in the Australian healthcare system and are committed to working collaboratively with GPs and other allied healthcare professionals to deliver integrated health care solutions to the community that result in improved health outcomes," Nevile said.
"In health care, it is essential that patients are the central focus, and our health screening services have been designed to engage or re-engage patients with their GP and the wider health care system united by the common goal of improving health outcomes."
As part of the service, Amcal will offer clinical bundles including diabetes, heart, kidney, fatigue, vitamin D deficiency and general health and wellbeing bundles.
Nevile added that with patients as the central focus, and doctors as the most appropriate and qualified to explain and discuss abnormal or out of range pathology results, "Amcal pharmacists will refer patients to their GPs and specialist for follow up as appropriate."
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Jun 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Jun 17